These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22743658)

  • 1. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.
    Kruer MC; Paudel R; Wagoner W; Sanford L; Kara E; Gregory A; Foltynie T; Lees A; Bhatia K; Hardy J; Hayflick SJ; Houlden H
    Neurosci Lett; 2012 Aug; 523(1):35-8. PubMed ID: 22743658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.
    Engel LA; Jing Z; O'Brien DE; Sun M; Kotzbauer PT
    PLoS One; 2010 Sep; 5(9):e12897. PubMed ID: 20886109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.
    Kapoor S; Shah MH; Singh N; Rather MI; Bhat V; Gopinath S; Bindu PS; Taly AB; Sinha S; Nagappa M; Bharath RD; Mahadevan A; Narayanappa G; Chickabasaviah YT; Kumar A
    PLoS One; 2016; 11(5):e0155605. PubMed ID: 27196560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
    Nishioka K; Oyama G; Yoshino H; Li Y; Matsushima T; Takeuchi C; Mochizuki Y; Mori-Yoshimura M; Murata M; Yamasita C; Nakamura N; Konishi Y; Ohi K; Ichikawa K; Terada T; Obi T; Funayama M; Saiki S; Hattori N
    Neurobiol Aging; 2015 May; 36(5):2004.e9-2004.e15. PubMed ID: 25744623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
    Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family.
    Sina F; Shojaee S; Elahi E; Paisán-Ruiz C
    Eur J Neurol; 2009 Jan; 16(1):101-4. PubMed ID: 19087156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
    Schneider SA; Paisan-Ruiz C; Quinn NP; Lees AJ; Houlden H; Hardy J; Bhatia KP
    Mov Disord; 2010 Jun; 25(8):979-84. PubMed ID: 20310007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.
    Brüggemann N; Hagenah J; Reetz K; Schmidt A; Kasten M; Buchmann I; Eckerle S; Bähre M; Münchau A; Djarmati A; van der Vegt J; Siebner H; Binkofski F; Ramirez A; Behrens MI; Klein C
    Arch Neurol; 2010 Nov; 67(11):1357-63. PubMed ID: 21060012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLA2G6-associated neurodegeneration in four different populations-case series and literature review.
    Hanna Al-Shaikh R; Milanowski LM; Holla VV; Kurihara K; Yadav R; Kamble N; Muthusamy B; Bellad A; Koziorowski D; Szlufik S; Hoffman-Zacharska D; Fujioka S; Tsuboi Y; Ross OA; Wierenga K; Uitti RJ; Wszolek Z; Pal PK
    Parkinsonism Relat Disord; 2022 Aug; 101():66-74. PubMed ID: 35803092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.
    Salomão RP; Pedroso JL; Gama MT; Dutra LA; Maciel RH; Godeiro-Junior C; Chien HF; Teive HA; Cardoso F; Barsottini OG
    Arq Neuropsiquiatr; 2016 Jul; 74(7):587-96. PubMed ID: 27487380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare causes of dystonia parkinsonism.
    Schneider SA; Bhatia KP
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):431-9. PubMed ID: 20694531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
    Chu YT; Lin HY; Chen PL; Lin CH
    BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration with brain iron accumulation.
    Hayflick SJ; Kurian MA; Hogarth P
    Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile dystonia-parkinsonism syndrome caused by a novel p.S941Tfs1X ATP13A2 (PARK9) mutation.
    Martino D; Melzi V; Franco G; Kandasamy N; Monfrini E; Di Fonzo A
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1378-80. PubMed ID: 26421390
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases.
    Kolarova H; Tan J; Strom TM; Meitinger T; Wagner M; Klopstock T
    EBioMedicine; 2022 Mar; 77():103869. PubMed ID: 35180557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.
    Yamashita C; Funayama M; Li Y; Yoshino H; Yamada H; Seino Y; Tomiyama H; Hattori N
    J Neural Transm (Vienna); 2017 Apr; 124(4):431-435. PubMed ID: 27942883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION].
    Ács P; Molnár MJ; Klivényi P; Kálmán B
    Ideggyogy Sz; 2016 Mar; 69(5-6):157-66. PubMed ID: 27468605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.